The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML).
 
Courtney Denton Dinardo
Leadership - Notable Labs
Stock and Other Ownership Interests - Notable Labs
Honoraria - Abbvie; Agios; Bluebird Bio; Celgene; Foghorn Therapeutics; Genentech/Abbvie; Genmab; GlaxoSmithKline; Jazz Pharmaceuticals; Novartis; SERVIER; Takeda
Consulting or Advisory Role - Abbvie; Agios; Celgene; GlaxoSmithKline
Research Funding - Abbvie; AGIOS; Celgene; Cleave Therapeutics; Daiichi Sankyo; Foghorn Therapeutics; Immune-Onc Therapeutics; Jazz Pharmaceuticals
 
Pau Montesinos
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Andre C. Schuh
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Agios; Amgen; Celgene; Pfizer
 
Cristina Papayannidis
No Relationships to Disclose
 
Paresh Vyas
Honoraria - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
Andrew H. Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Clara Chen
No Relationships to Disclose
 
Jennifer Lord-Bessen
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Peiwen Yu
Employment - Evidera/PPD
 
Ling Shi
Employment - Evidera/PPD
Stock and Other Ownership Interests - PPD Global
 
Shien Guo
Employment - Evidera
Leadership - Evidera
Stock and Other Ownership Interests - PPD
Consulting or Advisory Role - Evidera (Inst)
 
Iryna Bluemmert
Employment - Bristol-Myers Squibb
 
Xin Yu
Employment - Bristol-Myers Squibb; Regeneron (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Regeneron (I)
 
Maroof Hasan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Patricia Martin Regueira
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stéphane De Botton
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Auron Therapeutics; Forma Therapeutics
Travel, Accommodations, Expenses - Abbvie; SERVIER